跳至主要内容
临床试验/NL-OMON46827
NL-OMON46827招募中不适用

Cholangiocarcinoma detection using an intraOperative FlUorescence Image Guided Approach with Bevacizumab-IRDye 800CW - COUGAR

niversitair Medisch Centrum Groningen0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age older or equal to 18 year
  • - Patients with suspected perihilar cholangiocarcinoma who are scheduled to undergo surgical intervention with curative intent
  • - WHO performance score 0-2

排除标准

  • - Medical or psychiatric conditions that compromise the patient's ability to give informed consent.
  • - Other invasive malignancy
  • - Pregnant or lactating women.
  • - History of infusion reactions to bevacizumab
  • - Inadequately controlled hypertension with or without current antihypertensive medications
  • - Within 6 months prior to inclusion: myocardial infarction, TIA, CVA, pulmonary embolism, uncontrolled chronic hepatic failure, unstable angina pectoris

研究者

相似试验